The Health Care M&A Monthly: McKesson Buys US Oncology–
Enlarges Cancer Drug Distribution Business Early in November, the media heralded the acquisition of US Oncology by McKesson Corporation (NYSE: MCK) as a sign that the economy was rebounding. After all, they reasoned, committing to pay $2.16 billion in the current...The Health Care M&A Monthly: The Big Spenders Of 2010–
37 Buyers Spent $1.0 Billion Or More On Health Care M&A From years past, we have come to expect a lull in merger and acquisition activity from Thanksgiving through New Year’s Day. Instead of announcing new, large transactions, dealmakers typically use the holiday...The Health Care M&A Monthly: Seniors Housing Deals In Focus–
October Produces Six Deals Worth Over $3.2 Billion Toward the end of each year, we see a flurry of transactions in the Long-Term Care sector as brokers, bankers and principals try to tie up the deals they have been working on so diligently. During the third quarter of...The Health Care M&A Monthly: Pfizer Rejoins The Fray–
Makes Three Deals Worth $4.2 Billion In One Month Since acquiring Wyeth last year for $68.0 billion, Pfizer (NYSE: PFE) has kept a relatively low acquisition profile, buying a biotech here, a generic pharma there, all for relatively small amounts. That changed this...The Health Care M&A Monthly: Third Quarter M&A Results–
215 Deals Posted Worth $65.9 Billion Based on preliminary data, the health care industry posted a total of 215 mergers and acquisitions in the third quarter of 2010. A total of $65.9 billion was committed to fund this activity. Despite a lower level in deal volume,...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
